Terms: = Germ cell tumor AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
700 results:
1. Antiproliferative effect of Potentilla fulgens on glioblastoma cancer cells through downregulation of Akt/mTOR signaling pathway.
Kandemir SI; Ipek P
J Cancer Res Ther; 2023 Oct; 19(7):1818-1824. PubMed ID: 38376284
[TBL] [Abstract] [Full Text] [Related]
2. Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
Vagaggini C; Petroni D; D'Agostino I; Poggialini F; Cavallini C; Cianciusi A; Salis A; D'Antona L; Francesconi V; Manetti F; Damonte G; Musumeci F; Menichetti L; Dreassi E; Carbone A; Schenone S
Drug Dev Res; 2024 Feb; 85(1):e22158. PubMed ID: 38349262
[TBL] [Abstract] [Full Text] [Related]
3. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
Bai X; Li S; Luo Y
Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
[TBL] [Abstract] [Full Text] [Related]
4. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
[TBL] [Abstract] [Full Text] [Related]
5. Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLCγ1 signaling through src-family kinases.
Peng WY; Abere B; Shi H; Toland S; Smithgall TE; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2316467120. PubMed ID: 38079542
[TBL] [Abstract] [Full Text] [Related]
6. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.
Lv D; Zhong C; Dixit D; Yang K; Wu Q; Godugu B; Prager BC; Zhao G; Wang X; Xie Q; Bao S; He C; Heiland DH; Rosenfeld MG; Rich JN
Mol Cell; 2023 Dec; 83(23):4334-4351.e7. PubMed ID: 37979586
[TBL] [Abstract] [Full Text] [Related]
7. Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
Guo D; Jurek R; Beaumont KA; Sharp DS; Tan SY; Mariana A; Failes TW; Grootveld AK; Bhattacharyya ND; Phan TG; Arndt GM; Jain R; Weninger W; Tikoo S
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2303978120. PubMed ID: 37963252
[TBL] [Abstract] [Full Text] [Related]
8. NRF2 connects src tyrosine kinase to ferroptosis resistance in glioblastoma.
Cirotti C; Taddei I; Contadini C; Di Girolamo C; Pepe G; De Bardi M; Borsellino G; Helmer-Citterich M; Barilà D
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37879937
[TBL] [Abstract] [Full Text] [Related]
9. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract] [Full Text] [Related]
10. Indoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells.
Guo X; Fan A; Qi X; Liu D; Huang J; Lin W
Bioorg Chem; 2023 Dec; 141():106873. PubMed ID: 37734192
[TBL] [Abstract] [Full Text] [Related]
11. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract] [Full Text] [Related]
12. Early Immune Changes Support Signet Ring cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis.
Green BL; Gamble LA; Diggs LP; Nousome D; Patterson JC; Joughin BA; Gasmi B; Lux SC; Samaranayake SG; Miettinen M; Quezado M; Hernandez JM; Yaffe MB; Davis JL
Mol Cancer Res; 2023 Dec; 21(12):1356-1365. PubMed ID: 37707375
[TBL] [Abstract] [Full Text] [Related]
13. Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking.
Su J; Huo M; Xu F; Ding L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1551-1559. PubMed ID: 37668687
[TBL] [Abstract] [Full Text] [Related]
14. Using evolutionary constraint to define novel candidate driver genes in medulloblastoma.
Roy A; Sakthikumar S; Kozyrev SV; Nordin J; Pensch R; Mäkeläinen S; Pettersson M; ; Karlsson EK; Lindblad-Toh K; Forsberg-Nilsson K
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2300984120. PubMed ID: 37549291
[TBL] [Abstract] [Full Text] [Related]
15. EGFR-Induced and c-src-Mediated CD47 Phosphorylation Inhibits TRIM21-Dependent Polyubiquitylation and Degradation of CD47 to Promote tumor Immune Evasion.
Du L; Su Z; Wang S; Meng Y; Xiao F; Xu D; Li X; Qian X; Lee SB; Lee JH; Lu Z; Lyu J
Adv Sci (Weinh); 2023 Sep; 10(27):e2206380. PubMed ID: 37541303
[TBL] [Abstract] [Full Text] [Related]
16. Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma cells.
Hardin HM; Dinh CT; Huegel J; Petrilli AM; Bracho O; Allaf AM; Karajannis MA; Griswold AJ; Ivan ME; Morcos J; Gultekin SH; Telischi FF; Liu XZ; Fernandez-Valle C
Mol Cancer Ther; 2023 Nov; 22(11):1280-1289. PubMed ID: 37527526
[TBL] [Abstract] [Full Text] [Related]
17. METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling.
Yin J; Ding F; Cheng Z; Ge X; Li Y; Zeng A; Zhang J; Yan W; Shi Z; Qian X; You Y; Ding Z; Ji J; Wang X
Cell Death Dis; 2023 Jul; 14(7):417. PubMed ID: 37438359
[TBL] [Abstract] [Full Text] [Related]
18. Suppression of sonic hedgehog pathway-based proliferation in glioblastoma cells by small-size silver nanoparticles in vitro.
Skóra B; Masicz M; Nowak P; Lachowska J; Sołtysek P; Biskup J; Matuszewska P; Szychowski KA
Arch Toxicol; 2023 Sep; 97(9):2385-2398. PubMed ID: 37407723
[TBL] [Abstract] [Full Text] [Related]
19. Dynamic interplay between corticosteroid treatment and the role of src-1 gene dysregulation in the progression of WHO-Grade 4 Astrocytoma.
Kurdi M; Fadul MM; Addas BMJ; Faizo E; Alkhayyat S; Bamaga AK; Alsinani T; Katib Y; Okal F; Maghrabi Y; Sabbagh AJ; Moshref R; Albalawi S; Alkhotani A; Halawa TF; Mulla N; Hakamy S; Baeesa S
J Neurooncol; 2023 Jul; 163(3):693-705. PubMed ID: 37402091
[TBL] [Abstract] [Full Text] [Related]
20. Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
Biswas A; Salvucci M; Connor K; Düssmann H; Carberry S; Fichtner M; King E; Murphy B; O'Farrell AC; Cryan J; Beausang A; Heffernan J; Cremona M; Hennessy BT; Clerkin J; Sweeney KJ; MacNally S; Brett F; O'Halloran P; Bacon O; Furney S; Verreault M; Quissac E; Bielle F; Ahmed MH; Idbaih A; Leenstra S; Ntafoulis I; Fabro F; Lamfers M; Golebiewska A; Hertel F; Niclou SP; Yen RTC; Kremer A; Dilcan G; Lodi F; Arijs I; Lambrechts D; Purushothama MK; Kel A; Byrne AT; Prehn JHM
J Neurooncol; 2023 Jun; 163(2):327-338. PubMed ID: 37237151
[TBL] [Abstract] [Full Text] [Related]
[Next]
